What is Podimetrics?
Founded in 2011, Podimetrics operates as a specialized care management company focused on the prevention of diabetic foot ulcers. The company's core value proposition lies in its ability to provide proactive, technology-driven monitoring that identifies potential issues before they escalate into severe clinical events. By integrating advanced diagnostic tools with a robust support infrastructure, Podimetrics addresses a significant unmet need in the management of diabetes, a condition that remains a primary driver of healthcare costs globally. Their market position is defined by a commitment to clinical efficacy and the seamless adoption of their technology within existing provider workflows, ensuring that patients receive timely interventions that improve long-term health outcomes.
How much funding has Podimetrics raised?
Podimetrics has raised a total of $105.1M across 7 funding rounds:
Angel/Seed
$2.5M
Debt
$1.2M
Series A
$5.8M
Debt
$1M
Series B
$24.6M
Series C
$45M
Debt
$25M
Angel/Seed (2013): $2.5M, investors not publicly disclosed
Debt (2014): $1.2M, investors not publicly disclosed
Series A (2016): $5.8M, investors not publicly disclosed
Debt (2017): $1M, investors not publicly disclosed
Series B (2020): $24.6M backed by Scientific Health Development, Rock Health companies, and Norwich Ventures
Series C (2022): $45M with participation from D1 Capital Partners and Medtech Convergence Fund
Debt (2022): $25M led by CIBC Innovation Banking
Key Investors in Podimetrics
Scientific Health Development
Scientific Health Development is a Dallas-based venture capital firm specializing in early-stage medtech companies that address unmet clinical needs with easily adoptable technologies.
Rock Health
Rock Health is a dedicated investment firm focused on supporting entrepreneurs at the intersection of healthcare and technology to drive systemic improvements in patient care.
Norwich Ventures
Norwich Ventures is a specialized venture capital firm that provides early-stage capital to medtech innovators, emphasizing a long-term perspective on clinical and commercial success.
What's next for Podimetrics?
With the recent infusion of $25M, Podimetrics is well-positioned to accelerate its strategic roadmap, focusing on the expansion of its patient monitoring network and the enhancement of its data analytics capabilities. The company is expected to leverage this capital to deepen its penetration in the enterprise healthcare market, potentially exploring new partnerships with large-scale health systems and payers. As the demand for remote, value-based care continues to rise, Podimetrics is poised to capitalize on its established clinical foundation to drive further innovation in preventative medicine. Future growth will likely center on scaling its operational footprint while maintaining the high standards of care that have characterized its development to date.
See full Podimetrics company page
